Welcome to the website of the Global Bioanalysis Consortium (GBC)
Global Bioanalysis Consortium Webinars
Outcomes of the GBC Harmonization Teams on Bioanalytical Method Validation
The GBC announces two Webinars presenting key recommendations from the Harmonization Teams. The Harmonization teams were grouped under broad categories of topics related to 1) all chemotypes, 2) chromatographic-based assays and 3) Ligand-binding assays. To minimize the number of webinars most attendees are interested in, the topics for all chemotypes have been grouped with both the chromatographic assays and ligand-binding assay content producing just two sessions. Each Webinar session will be presented twice to accommodate all regions
The Global Bioanalysis Consortium (GBC) is a world wide organisation consisting of representatives of scientific associations with the mission to harmonize and merge existing or emerging bioanalytical guidances to create one, unified consensus document that can be presented to the regulatory bodies/health authorities in various countries.
Our Goals and Objectives:
To bring together stakeholders from the pharmaceutical industry, contract research organizations and academia to share current understanding of bioanalysis guidelines, identify differences in these guidelines or differences in the interpretation or application thereof to routine regulated bioanalysis. To come forward with recommendations to Health Authorities and regulatory bodies worldwide on globally agreed best practices for Bioanalytical Method Validation (BMV) and application of such methods/technologies to the analysis of drugs of all molecular sizes in support of clinical and nonclinical studies.
The views expressed on this website are those of the Global Bioanalysis Consortium and do not necessarily reflect the representative affiliation or company's position on the subject.